Corcept Therapeutics Incorporated (CORT) — Cash Flow Reinvestment Rate
Corcept Therapeutics Incorporated (CORT) has a Cash Flow Reinvestment Rate of 0.31x as of December 2025, reinvesting $11.84 Million (capex $50.00K plus investments $-11.79 Million) from operating cash flow of $38.45 Million. Check earnings quality score of Corcept Therapeutics Incorporated to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Corcept Therapeutics Incorporated Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Corcept Therapeutics Incorporated across 11 annual periods. Explore Corcept Therapeutics Incorporated (CORT) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Corcept Therapeutics Incorporated (2015–2025)
Year-by-year capital reinvestment analysis for Corcept Therapeutics Incorporated. For live market cap and broader valuation context, see how much is Corcept Therapeutics Incorporated worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | $70.18 Million | $142.00 Million | $211.00K | ▼ -45.5% |
| 2024 | 0.91x | $179.78 Million | $198.07 Million | $2.17 Million | ▲ +103.3% |
| 2023 | 0.45x | $56.71 Million | $127.04 Million | $139.00K | ▼ -53.2% |
| 2022 | 0.95x | $114.74 Million | $120.32 Million | $413.00K | ▲ +16.8% |
| 2021 | 0.82x | $137.06 Million | $167.89 Million | $469.00K | ▲ +4.0% |
| 2020 | 0.78x | $119.26 Million | $151.97 Million | $1.24 Million | ▼ -9.3% |
| 2019 | 0.87x | $117.83 Million | $136.12 Million | $1.09 Million | ▲ +10.3% |
| 2018 | 0.78x | $90.77 Million | $115.67 Million | $298.00K | ▼ -34.9% |
| 2017 | 1.21x | $73.46 Million | $60.94 Million | $419.00K | ▲ +5613.9% |
| 2016 | 0.02x | $388.00K | $18.39 Million | $194.00K | ▼ -99.9% |
| 2015 | 23.34x | $73.05 Million | $3.13 Million | $17.00K | — |